Subscribe to daily free stock newsletter on top stocks by visiting : http://www.pennystockpickreport.com/
Compugen Ltd. (
PSivida Corp. (NASDAQ:PSDV) soared 54.24% to 55.43 after pSivida Corp. announced the top-line 24 month results from the Phase III FAME study of Iluvien for the treatment of Diabetic Macular Edema (DME) being conducted by pSivida's collaborative partner Alimera Sciences. The FAME study was designed as two Phase 3 pivotal clinical trials (Trial A and Trial B). 956 patients with DME were enrolled and randomized to receive either a high dose Iluvien (0.45 µg/day), a low dose Iluvien (0.23 µg/day) or a sham insertion.
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) jumped 14.50% to $3.64 after Analysts at Roth Capital Partners initiated coverage of the small-cap stock with a buy rating. Achillion Pharmaceuticals, Inc. (Achillion) is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases.
About http://www.pennystockpickreport.com/
Penny Stock Pick Report offers a stock newsletter on OTC, PINKSHEETS ,OTCBB, and AMEX Stocks. Our subscribers receive daily up to date stock information on midcap, smallcap penny stocks and also stocks that are traded at NASDAQ and NYSE stock exchange. If you wish to feature your organization on our website then you can contact us at the email given below.